Kubota Pharmaceutical Holdings Co., Ltd.

OTCPK:KBBT.F Stock Report

Market Cap: US$46.0m

Kubota Pharmaceutical Holdings Management

Management criteria checks 2/4

Kubota Pharmaceutical Holdings' CEO is Ryo Kubota, appointed in Jan 2002, has a tenure of 21.17 years. directly owns 18.66% of the company’s shares, worth $8.59M. The average tenure of the management team and the board of directors is 7.8 years and 2.2 years respectively.

Key information

Ryo Kubota

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure21.2yrs
CEO ownership18.7%
Management average tenure7.8yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ryo Kubota's remuneration changed compared to Kubota Pharmaceutical Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022n/an/a

-JP¥2b

Sep 30 2022n/an/a

-JP¥2b

Jun 30 2022n/an/a

-JP¥2b

Mar 31 2022n/an/a

-JP¥3b

Dec 31 2021n/an/a

-JP¥3b

Sep 30 2021n/an/a

-JP¥2b

Jun 30 2021n/an/a

-JP¥3b

Mar 31 2021n/an/a

-JP¥2b

Dec 31 2020n/an/a

-JP¥2b

Sep 30 2020n/an/a

-JP¥3b

Jun 30 2020n/an/a

-JP¥3b

Mar 31 2020n/an/a

-JP¥3b

Dec 31 2019n/an/a

-JP¥3b

Sep 30 2019n/an/a

-JP¥3b

Jun 30 2019n/an/a

-JP¥3b

Mar 31 2019n/an/a

-JP¥3b

Dec 31 2018JP¥85mJP¥62m

-JP¥3b

Sep 30 2018n/an/a

-JP¥3b

Jun 30 2018n/an/a

-JP¥3b

Mar 31 2018n/an/a

-JP¥3b

Dec 31 2017n/an/a

-JP¥3b

Sep 30 2017n/an/a

-JP¥4b

Jun 30 2017n/an/a

-JP¥3b

Mar 31 2017n/an/a

-JP¥3b

Dec 31 2016JP¥564mJP¥62m

-JP¥4b

Compensation vs Market: Insufficient data to establish whether Ryo's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Ryo's compensation has been consistent with company performance over the past year.


CEO

Ryo Kubota (56 yo)

21.2yrs

Tenure

JP¥84,604,000

Compensation

Dr. Ryo Kubota, M.D., Ph D., Founded Acucela Inc. in 2002 and has been its Chairman since April 2005, Chief Executive Officer and President since December 2015. Dr. Kubota Founded Kubota Pharmaceutical Hol...


Leadership Team

NamePositionTenureCompensationOwnership
Ryo Kubota
Founder21.2yrsJP¥84.60m18.66%
¥ 8.6m
Tomomi Sukagawa
Director of Investor Relations & Communicationno datano datano data
Edward Danse
Chief Business Officer of Acucela Inc7.8yrsJP¥59.49mno data
Lukas Scheibler
Executive Vice President of Research & Development - Acucela Inc7.6yrsJP¥178.53mno data

7.8yrs

Average Tenure

56yo

Average Age

Experienced Management: KBBT.F's management team is seasoned and experienced (7.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ryo Kubota
Founder20.8yrsJP¥84.60m18.66%
¥ 8.6m
Shintaro Asako
Lead Independent Director7yrsJP¥60.14m0.0015%
¥ 672.2
Shingo Tsuda
Director2.2yrsno data0.00018%
¥ 82.9
Mikio Fukai
Director1.2yrsno datano data
Emiko Maki
Director1.2yrsno datano data

2.2yrs

Average Tenure

Experienced Board: KBBT.F's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.